Sebacia Microparticles

DEVICE2 trials

Sponsors

Sebacia, Inc.

Conditions

Acne VulgarisFacial Acne Vulgaris

Unknown Phase

A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

CompletedNCT02758041

Sebacia, Inc.Facial Acne Vulgaris

Start: 2016-02-29End: 2017-02-28Updated: 2017-09-07

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

CompletedNCT03303170

Sebacia, Inc.Acne Vulgaris

Start: 2017-09-25End: 2018-04-10Updated: 2019-10-14